papaverine has been researched along with Tachycardia, Ventricular in 7 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the effect of the papaverine dose increment method to confirm maximal hyperemia for fractional flow reserve (FFR) measurements." | 7.96 | Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine. ( Iwasaki, K; Nakayama, M; Tanaka, N; Yamashita, J, 2020) |
" Intracoronary papaverine (PAP) is the most potent vasodilator used for the achievement of maximal hyperemia." | 4.02 | Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement. ( Anai, R; Araki, M; Inoue, K; Kataoka, M; Miura, T; Naka, Y; Okabe, H; Setoyama, K; Sonoda, S, 2021) |
"We investigated the effect of the papaverine dose increment method to confirm maximal hyperemia for fractional flow reserve (FFR) measurements." | 3.96 | Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine. ( Iwasaki, K; Nakayama, M; Tanaka, N; Yamashita, J, 2020) |
"Three cases with polymorphous ventricular tachycardia following a standard dose of intracoronary papaverine during 102 measurements of coronary flow reserve are reported." | 1.29 | Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases. ( Cai, X; Shen, W; Zhang, X; Zheng, A, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Inoue, K | 1 |
Sonoda, S | 1 |
Naka, Y | 1 |
Okabe, H | 1 |
Setoyama, K | 1 |
Miura, T | 1 |
Anai, R | 1 |
Araki, M | 1 |
Kataoka, M | 1 |
Nakayama, M | 3 |
Tanaka, N | 3 |
Yamashita, J | 2 |
Iwasaki, K | 1 |
Nauchi, M | 1 |
Sakai, T | 1 |
Yamawaki, M | 1 |
Ito, Y | 1 |
Sakoda, K | 1 |
Hokama, Y | 1 |
Hoshino, K | 2 |
Kimura, Y | 1 |
Ogawa, M | 1 |
Kobori, Y | 1 |
Uchiyama, T | 1 |
Aizawa, Y | 2 |
Yamashina, A | 2 |
Saito, A | 1 |
Kitazawa, H | 1 |
Takahashi, M | 1 |
Sato, M | 1 |
Fuse, K | 1 |
Okabe, M | 1 |
HARRIS, AS | 1 |
ESTANDIA, A | 1 |
BISTENI, A | 1 |
SMITH, HT | 1 |
Zhang, X | 1 |
Shen, W | 1 |
Cai, X | 1 |
Zheng, A | 1 |
7 other studies available for papaverine and Tachycardia, Ventricular
Article | Year |
---|---|
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Coronary Angiography; Coronary | 2021 |
Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine.
Topics: Aged; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Dose-Response Relationship, Drug; E | 2020 |
Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve.
Topics: Aged; Coronary Vessels; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Humans; Pa | 2018 |
Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease.
Topics: Aged; Coronary Artery Disease; Electrocardiography; Female; Humans; Incidence; Male; Middle Aged; Pa | 2015 |
Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases.
Topics: Aged; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Electrocardiography; Female; Fracti | 2012 |
Effects of papaverine upon ectopic ventricular tachycardia produced by myocardial infarction.
Topics: Myocardial Infarction; Papaverine; Tachycardia; Tachycardia, Ventricular; Ventricular Premature Comp | 1953 |
Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases.
Topics: Adult; Aged; Coronary Angiography; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Pa | 1993 |